Testosterone Med Recalled

More than 83,000 single-dose, 1-mL vials of testosterone cypionate injection, USP, 200 mg/mL, are being voluntarily recalled by Sun Pharmaceutical Industries, Inc, according to a recent US Food and Drug Administration (FDA) Enforcement Report.

Four lots of the prescription medication—used as replacement therapy in male patients who have conditions that are linked to symptoms of testosterone deficiency or absence—are included in the recall, which was classified as Class II by the FDA.

The recall affects vials with the following code information: JKR0744A, JKR0745A, JKR0750A, and JKR0795A (expiration date for all, 09/18). The impacted vials were distributed throughout the United States.

Sun Pharmaceutical Industries, Inc, initiated the recall on March 15, 2017, and it is currently in progress.

--Meredith Edwards White